newsfilter
← Latest News
GlobeNewswire·

Galecto to Participate in Upcoming Investor Conferences

BOSTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ:GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and severe liver diseases, today announced that